What's new

EMEA-003405-PIP01-23

EMEA-003405-PIP01-23

Jun 6, 2025 - 12:20
 0
EMEA-003405-PIP01-23
EMEA-003405-PIP01-23
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Da...

Next Article

PRAC concludes eye condition NAION is a very rare side effect of semaglutide med...

Related Posts

EMEA-002042-PIP03-23

EMEA-002042-PIP03-23

Jun 6, 2025  0

Minutes of the HMPC meeting 17-19 March 2025

May 12, 2025  0

Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 15/11/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0